We are live on ! Find out more
EQHA.WS

EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS

Delisted

EQHA.WS was delisted on the 25th of November, 2022.

63 hedge funds and large institutions have $5.58M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

3% more funds holding

Funds holding: 6163 (+2)

1% less capital invested

Capital invested by funds: $5.61M → $5.58M (-$38K)

Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
5
Closed
1
Calls
$4.36M
Puts
Net Calls
+$4.36M
Net Calls Change
+$14K

EQHA.WS Hedge Fund Activity: Q3 2022 in Review

63 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q3 2022, worth a combined $5.58M — down 0.68% from $5.61M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EQHA.WS positions and 1 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $25.4K. The largest seller was K.J. Harrison & Partners, cutting an estimated $15K.

  • 63 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q3 2022, up from 61 in Q2 2022.
  • Funds reported $5.58M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2022, down 0.68% quarter-over-quarter.
  • 3 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2022 and 1 closed out, a net change of +2 holders.
  • The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2022 was Magnetar Financial, an estimated $25.4K added.
  • The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2022 was K.J. Harrison & Partners, an estimated $15K sold.

Based on aggregated 13F filings for Q3 2022.